title: Continuous glucose control in the ICU: report of a 2013 round table meeting.
abstract: Achieving adequate glucose control in critically ill patients is a complex but important part of optimal patient management. Until relatively recently, intermittent measurements of blood glucose have been the only means of monitoring blood glucose levels. With growing interest in the possible beneficial effects of continuous over intermittent monitoring and the development of several continuous glucose monitoring (CGM) systems, a round table conference was convened to discuss and, where possible, reach consensus on the various aspects related to glucose monitoring and management using these systems. In this report, we discuss the advantages and limitations of the different types of devices available, the potential advantages of continuous over intermittent testing, the relative importance of trend and point accuracy, the standards necessary for reporting results in clinical trials and for recognition by official bodies, and the changes that may be needed in current glucose management protocols as a result of a move towards increased use of CGM. We close with a list of the research priorities in this field, which will be necessary if CGM is to become a routine part of daily practice in the management of critically ill patients.
authors.forename: Jan
authors.initials: J
authors.lastname: Wernerman
authors.forename: Thomas
authors.initials: T
authors.lastname: Desaive
authors.forename: Simon
authors.initials: S
authors.lastname: Finfer
authors.forename: Luc
authors.initials: L
authors.lastname: Foubert
authors.forename: Anthony
authors.initials: A
authors.lastname: Furnary
authors.forename: Ulrike
authors.initials: U
authors.lastname: Holzinger
authors.forename: Roman
authors.initials: R
authors.lastname: Hovorka
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Joseph
authors.forename: Mikhail
authors.initials: M
authors.lastname: Kosiborod
authors.forename: James
authors.initials: J
authors.lastname: Krinsley
authors.forename: Dieter
authors.initials: D
authors.lastname: Mesotten
authors.forename: Stanley
authors.initials: S
authors.lastname: Nasraway
authors.forename: Olav
authors.initials: O
authors.lastname: Rooyackers
authors.forename: Marcus J
authors.initials: MJ
authors.lastname: Schultz
authors.forename: Tom
authors.initials: T
authors.lastname: Van Herpe
authors.forename: Robert A
authors.initials: RA
authors.lastname: Vigersky
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Preiser
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D003226:Congresses as Topic; D003422:Critical Care / Q000379:methods*; D016638:Critical Illness; D006801:Humans; D007362:Intensive Care Units; D008991:Monitoring, Physiologic / Q000379:methods*
chemical_list: D001786:Blood Glucose